Join
Live feed
·
INSIDERFilingvia Quantisnow
Tango Therapeutics Inc. logo

President, R&D Crystal Adam sold $694,208 worth of shares (54,345 units at $12.77), decreasing direct ownership by 29% to 132,873 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
TNGX· Tango Therapeutics Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track TNGX (Tango Therapeutics Inc.) and more on Quantisnow.